[Proper Perioperative Handling of Continuous Medication in Patients with Cardiac Comorbidities]

Insights

Managing cardiac comorbidities like arterial hypertension (AHT), congestive heart failure (CHF), and coronary artery disease (CAD) is crucial for perioperative care. This review details current therapies and varying international guidelines for managing these conditions during surgery.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Internal Medicine

Background:

  • Cardiac comorbidities, including arterial hypertension (AHT), congestive heart failure (CHF), and coronary artery disease (CAD), represent a significant health burden in Germany.
  • AHT affects one-third of adults, while CHF impacts approximately 2.5 million individuals. CAD prevalence is notable in older populations.
  • Optimal perioperative care necessitates a thorough understanding of managing these cardiac conditions.

Purpose of the Study:

  • To review current medical therapies for prevalent cardiac comorbidities (AHT, CHF, CAD).
  • To analyze and compare international recommendations regarding the perioperative management of cardiac medications.
  • To provide a comprehensive resource for optimizing risk stratification and anesthesiological care.

Main Methods:

  • Systematic literature review of current medical therapies for AHT, CHF, and CAD.
  • Comparative analysis of guidelines from various countries and medical societies on perioperative drug management.
  • Synthesis of evidence to inform clinical practice.

Main Results:

  • Current medical therapies for AHT, CHF, and CAD are established, focusing on symptom management and disease progression.
  • Significant variability exists in recommendations for discontinuing or continuing cardiac medications perioperatively.
  • Lack of universal consensus complicates standardized patient care.

Conclusions:

  • Effective management of cardiac comorbidities requires up-to-date knowledge of treatment strategies.
  • Understanding the nuances in perioperative drug management is essential for patient safety.
  • Further harmonization of international guidelines could improve perioperative outcomes for patients with cardiac conditions.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
54
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
282
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
90
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
113
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
49
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
992